COMMUNIQUÉS West-GlobeNewswire

Trevi Therapeutics Announces Proposed Public Offering of Common Stock
16/04/2026
NEW HAVEN, Conn., April 16, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the [...]
Allogene Therapeutics Announces Closing of $200.4 Million Public Offering of Common Stock
16/04/2026
SOUTH SAN FRANCISCO, Calif., April 16, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO) today announced the closing of its previously announced underwritten public offering of 87,500,000 shares of its [...]
PacBio to Report First Quarter 2026 Financial Results on May 7, 2026
16/04/2026
MENLO PARK, Calif., April 16, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its first quarter 2026 financial results on Thursday, May 7, 2026, [...]
New Preclinical Data on STX-1, a First-in-Class Senolytic ADC, To Be Presented at AACR 2026
16/04/2026
PRESS RELEASE New Preclinical Data on STX-1, a First-in-Class Senolytic ADC, To Be Presented at AACR 2026 Presentations highlight therapy-induced senescence as a new therapeutic opportunity and reinforce the potential [...]
Emergent BioSolutions to Report First Quarter 2026 Financial Results on April 30, 2026
16/04/2026
GAITHERSBURG, Md., April 16, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, April 30, 2026, at 5:00 p.m. eastern time to discuss the financial results for the [...]
AB Science provides an update on its clinical development program.
16/04/2026
PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON ITS CLINICAL PROGRAM AB SCIENCE SECURES EUR 25 MILLION CLINICAL TRIAL INSURANCE FOR ITS PHASE III TRIAL IN AMYOTROPHIC LATERAL SCLEROSIS THE POLICY COVERS UP TO EUR 25 [...]
AB Science fait le point sur son programme de développement clinique
16/04/2026
COMMUNIQUÉ DE PRESSE AB SCIENCE FAIT LE POINT SUR SON PROGRAMME CLINIQUE AB SCIENCE OBTIENT UNE ASSURANCE D'ESSAIS CLINIQUES DE 25 MILLIONS D'EUROS POUR SON ETUDE DE PHASE III SUR LA SCLÉROSE LATÉRALE AMYOTROPHIQUE LA [...]
New Partnership to Accelerate Innovation in Kidney Research
16/04/2026
MONTREAL, April 16, 2026 (GLOBE NEWSWIRE) -- The Kidney Foundation of Canada is excited to announce a new research partnership with the Hyatt Family Foundation to support innovation in kidney care. Each organization has [...]
New National Platform Launches to Bridge the Gap in Bereavement Care: Introducing GriefSupportDirectory.com
16/04/2026
With Over 20,000 Listings, the Directory Connects Families to Local Grief Counseling, Support Groups, and Mental Health Resources Nationwide New York, NY, April 16, 2026 (GLOBE NEWSWIRE) -- My Grief Angels Inc, a leader [...]
ProtoFlow Claims Evaluated: The High Potency Prostate Support Ingredients for Day & Night Relief
16/04/2026
A 2026 informational overview of ProtoFlow's prostate support ingredients, formulation structure, and urinary wellness positioning — based on publicly available product details and published ingredient research. Aurora [...]
Somnee Smart Sleep Headband Claims Evaluated: Does It Work? Wearable Tech for Restorative Rest Support
16/04/2026
Somnee's neurostimulation technology, tACS research references, EEG sleep tracking capabilities, personalization process, membership structure, and general wellness positioning — outlined for consumers exploring non- [...]
Survey of Correctional Facility Staff: Monthly Opioid Treatment Shot May Help Reduce Medication Misuse
16/04/2026
RICHMOND, Va., April 16, 2026 (GLOBE NEWSWIRE) -- Indivior PLC (Nasdaq: INDV) today announced results from a national survey published in the Journal of Correctional Health Care showing that correctional leaders [...]
Disclosure of transparency notifications from BlackRock, Inc.
16/04/2026
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 16 April 2026 – 6 PM CET Disclosure of transparency notifications from BlackRock, Inc. Pursuant to the Belgian act of 2 May 2007 on the disclosure of [...]
Un nouveau partenariat pour accélérer la recherche innovante dans le domaine rénal
16/04/2026
MONTRÉAL, 16 avr. 2026 (GLOBE NEWSWIRE) -- La Fondation canadienne du rein est ravie d’annoncer un nouveau partenariat de recherche avec la Fondation de la famille Hyatt en vue de soutenir l’innovation dans le domaine [...]
Wake Radiology "Steps Up to the Plate" for Susan G. Komen Triangle Race for the Cure
16/04/2026
Raleigh, N.C., April 16, 2026 (GLOBE NEWSWIRE) -- Wake Radiology UNC Health Rex, the leading provider of outpatient medical imaging in the Triangle, is proud to announce its continued support for Susan G. Komen® , the [...]
Virbac: forte croissance de +7,7 % au premier trimestre 2026 à pcc, portée par la croissance à deux chiffres de nos plateformes prioritaires Supercharge⁴
16/04/2026
Le chiffre d'affaires du premier trimestre 2026 a atteint 384 M€ : +7,7 % à taux de change et périmètre constants par rapport au T1 2025. +2,2 % à taux réels, impactés par des effets de change significativement [...]
Evaxion concludes Annual General Meeting
16/04/2026
COPENHAGEN, Denmark, April 16, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, held its Annual General Meeting today [...]
Virbac: strong Q1 2026 growth of +7.7% at CERS, driven by double-digit growth of our priority Supercharge4 platforms
16/04/2026
First-quarter 2026 revenue reached €384m : +7.7% at constant exchange rate and scope (CERS) vs Q1 2025 +2.2% at actual rates impacted by significant currency headwinds Balanced growth in both segments : companion animal [...]
ENvue Issues Stockholder Letter & Provides Corporate Update
16/04/2026
TYLER, Texas, April 16, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing in the advancement of intelligent, non-invasive [...]

Pages